COPENHAGEN, Denmark, March 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and a consortium of health care institutions in Denmark have innovated a method to recycle used blood collection tubes without compromising hygiene, safety or quality of the material.

丹麦哥本哈根，2024年3月18日/新闻专线/--BD（Becton，Dickinson and Company）（纽约证券交易所：BDX），一家领先的全球医疗技术公司，以及丹麦一家医疗保健机构财团，创新了一种回收旧采血管的方法，而不影响材料的卫生，安全或质量。

BD partnered with Odense University Hospital, the Health Innovation Centre of Southern Denmark, the Danish Technological Institute, the Global Material & Asset Fund and EcoFITT ApS to conduct a feasibility study, which focused on used blood collection tubes from laboratories. The study shows that these used tubes, which are made from high-quality polyethylene terephthalate (PET) plastic, can be cleaned, shredded and molded into other types of new articles.

BD与欧登塞大学医院、丹麦南部健康创新中心、丹麦技术研究所、全球材料与资产基金和EcoFITT ApS合作进行了一项可行性研究，重点是实验室使用的采血管。研究表明，这些由优质聚对苯二甲酸乙二醇酯（PET）塑料制成的旧管可以清洗、切碎并模制成其他类型的新产品。

'Single-use plastic revolutionized health care, but we know there are environmental considerations that come with this critical innovation,' said Amit Limaye, director of the BD Sustainable Medical Technology Institute. 'BD is working with like-minded partners to drive sustainable innovation that will help reduce the environmental footprint of our product portfolio, while maintaining our high standards of patient safety, quality and efficacy.'.

BD可持续医疗技术研究所所长阿米特·利马耶（AmitLimaye）说，“一次性使用塑料彻底改变了医疗保健，但我们知道这一关键创新带来了环境因素BD正在与志同道合的合作伙伴合作，推动可持续创新，这将有助于减少我们产品组合的环境足迹，同时保持我们对患者安全，质量和疗效的高标准。”

Used blood collection tubes are considered biohazardous and regulated medical waste, and in Denmark, they are currently disposed through incineration. Considering the nature of their application, used blood tubes cannot be cleaned and reused like some other medical devices made of glass or metal. However, PET plastic is highly suitable for recycling and is one of the most recycled plastic materials.

用过的采血管被认为是生物危害和受管制的医疗废物，在丹麦，它们目前通过焚烧处理。考虑到其应用的性质，使用过的试管不能像其他一些由玻璃或金属制成的医疗器械那样进行清洁和重复使用。然而，PET塑料非常适合回收，是回收最多的塑料材料之一。

Further research is required to determine the best method for cleaning and recycling that optimize both the quality of the material and the climate impact of these processes. The study shows that by transitioning from incineration to recycling, 33 tonnes of high-quality plastic would be diverted from incineration within the region each year.

需要进一步的研究来确定最佳的清洁和回收方法，以优化材料的质量和这些过程对气候的影响。该研究表明，通过从焚烧转变为回收，该地区每年将有33吨优质塑料从焚烧中转移出去。

The collaborative effort was funded by the Region of Southern Denmark and is part of a broader effort to further progress toward Denmark's Climate Action Strategy, which aims to reduce the country's greenhouse gas emissions by 70 percent in 2030 compared to 1990 levels. To learn more about this study, visit the website of Health Innovation Centre of Southern Denmark, and to learn more about BD's commitments to net zero emissions, visit the BD newsroom.

这项合作工作由丹麦南部地区资助，是丹麦气候行动战略进一步取得进展的更广泛努力的一部分，该战略旨在2030年将该国温室气体排放量比1990年减少70%。要了解有关这项研究的更多信息，请访问丹麦南部健康创新中心的网站，要了解更多有关BD对净零排放的承诺，请访问BD新闻编辑室。

About BD

关于BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.

BD是世界上最大的全球医疗技术公司之一，正在通过改进医疗发现、诊断和护理服务来推动世界健康。该公司通过开发创新技术、服务和解决方案来支持医疗保健前线的英雄，这些技术、服务和解决方案有助于推进患者的临床治疗和医疗保健提供者的临床过程。

BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics.

BD及其70000多名员工充满热情并致力于帮助提高临床医生护理过程的安全性和效率，使实验室科学家能够准确检测疾病，并提高研究人员开发下一代诊断和治疗方法的能力。

BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

BD在几乎每个国家都有业务，并与世界各地的组织合作，以解决一些最具挑战性的全球健康问题。通过与客户密切合作，BD可以帮助提高成果，降低成本，提高效率，提高安全性并扩大医疗保健的范围。